Occurrence of Cardiovascular Complications Associated with SARS-CoV-2 Infection: A Systematic Review

被引:1
|
作者
Sardinha, Daniele Melo [1 ]
Batista Lima, Karla Valeria [2 ,3 ]
Rego Lopes Ueno, Thalyta Mariany [2 ]
Rodrigues, Yan Correa [2 ,3 ]
Dias Garcez, Juliana Conceicao [2 ]
Siqueira dos Santos, Anderson Lineu [2 ,3 ]
da Silva Ferreira, Ana Lucia [4 ]
de Paula Souza e Guimaraes, Ricardo Jose [1 ,5 ]
Gondim Costa Lima, Luana Nepomuceno [1 ,2 ,3 ]
机构
[1] Inst Evandro Chagas IEC, Programa Posgrad Epidemiol & Vigilancia Saud PPGE, BR-67030000 Ananindeua, Brazil
[2] Univ Estado Para UEPA, Programa Posgrad Biol Parasitaria Amazon PPGBPA, Inst Evandro Chagas IEC, BR-66087670 Belem, Para, Brazil
[3] Inst Evandro Chagas IEC, Secao Bacteriol & Micol SABMI, BR-67030000 Ananindeua, Brazil
[4] Secretaria Estado Saude Publ Para SESPA, BR-66017000 Belem, Para, Brazil
[5] Inst Evandro Chagas IEC, Lab Geoproc, BR-67030000 Ananindeua, Brazil
关键词
Cardiovascular complications; COVID-19; SARS-CoV-2; MYOCARDIAL INJURY; COVID-19; DISEASE; STRATEGY;
D O I
10.9734/JPRI/2021/v33i1431270
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cardiovascular Diseases represent the main cause of death in the world, and are associated with risk factors that cause serious complications in cases of infections, such as those of the respiratory tract. In March 2020 the World Health Organization declared a pandemic for SARS-CoV-2, a new coronavirus causing severe pneumonia, which emerged in December 2019 in Wuhan, China. The objective is to investigate the occurrence of cardiovascular complications associated with SARS-CoV-2 infection. It is a systematic review, quantitative, in the databases, PubMed and Science direct, including primary studies with hospitalized patients confirmed for COVID-19 and who presented cardiovascular complications, the form used tools for evaluation of quality and evidence, following the PRISMA recommendations. Results: 12 studies were included. The occurrence of cardiovascular complications was: 27.35% of the sample of 3,316 patients. Types: Acute cardiac injury 17.09%; Thromboembolism 4.73%; Heart failure 3.43%; Arrhythmias 1.77%; stroke 0.33%. Mean age 61 years. Conclusions: This study showed that there are several cardiovascular complications associated with SARS-CoV-2, that the main one is acute cardiac injury, which causes several instabilities in the cardiopulmonary system, and that it is associated with mortality.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview
    Gupta, Anamika
    Marzook, Hezlin
    Ahmad, Firdos
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (02) : 313 - 331
  • [32] Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview
    Anamika Gupta
    Hezlin Marzook
    Firdos Ahmad
    Clinical and Experimental Medicine, 2023, 23 : 313 - 331
  • [33] Association of Abnormal Cardiac Biomarkers and Cardiovascular Complications, with Mortality in Patients with SARS-CoV-2 Infection in Latin America
    Gomez-Mesa, Juan Esteban
    Escalante, Manuela
    Munoz-Ordonez, Juan Andres
    Azcarate-Rodriguez, Valeria
    Pelaez-Martinez, Juan David
    Arteaga-Tobar, Andrea Alejandra
    Leon-Giraldo, Hoover
    Valencia-Orozco, Andrea
    Perna, Eduardo Roque
    Romero, Alexander
    Mendoza, Ivan
    Wyss, Fernando
    Barisani, Jose Luis
    Speranza, Mario
    Alarco, Walter
    Herrera, Cesar
    Lugo-Pena, Julian
    Cardenas-Aldaz, Liliana Patricia
    Rossel, Victor
    Sierra, Daniel
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (07)
  • [34] Neurologic Manifestations and Complications of SARS-CoV-2 Infection A Narrative Review
    Del Brutto, Oscar
    Costa, Aldo F.
    Aguayo, Xavier
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2020, 28 (05) : 272 - 276
  • [35] Thyrotoxicosis occurrence in SARS-CoV-2 infection: A case report
    Pranasakti, Maria Erika
    Talirasa, Nimitta
    Rasena, Henda Ageng
    Purwanto, Rosita Yunanda
    Anwar, Sumadi Lukman
    ANNALS OF MEDICINE AND SURGERY, 2022, 78
  • [36] SARS-CoV-2 infection and cardiovascular disease
    Dezzani, Elena O.
    GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, 2022, 181 (09) : 599 - 604
  • [37] Cardiovascular disease in SARS-CoV-2 infection
    Sato, Kei
    Sinclair, Jane E.
    Sadeghirad, Habib
    Fraser, John F.
    Short, Kirsty R.
    Kulasinghe, Arutha
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (09)
  • [38] Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview
    Shiravi, Amir Abbas
    Ardekani, Ali
    Sheikhbahaei, Erfan
    Heshmat-Ghahdarijani, Kiyan
    CARDIOLOGY AND THERAPY, 2022, 11 (01) : 13 - 21
  • [39] Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview
    Amir Abbas Shiravi
    Ali Ardekani
    Erfan Sheikhbahaei
    Kiyan Heshmat-Ghahdarijani
    Cardiology and Therapy, 2022, 11 : 13 - 21
  • [40] Hyponatremia and SARS-CoV-2 infection: A narrative review
    Habas, Elmukhtar
    Ali, Elrazi
    Habas, Aml
    Rayani, Amnna
    Ghazouani, Hafedh
    Khan, Fahmi
    Farfar, Khalifa
    Elzouki, Abdel-Nasser
    MEDICINE, 2022, 101 (32) : E30061